{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:08:35Z","timestamp":1780315715538,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,8]]},"DOI":"10.7759\/cureus.44930","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T05:42:52Z","timestamp":1694238172000},"source":"Crossref","is-referenced-by-count":2,"title":["Classical Hodgkin Lymphoma on the Background of Castleman Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Ma'koseh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Al-Ibraheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidal","family":"Almasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Alrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195607\/08)9:4%3C822::aid-cncr2820090430%3E3.0.co;2-4","article-title":"Localized mediastinal lymphnode hyperplasia resembling thymoma","volume":"9","author":"Castleman B","year":"1956","unstructured":"Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956, 9:4-822. 10.1002\/1097-0142(195607\/08)9:4%3C822::aid-cncr2820090430%3E3.0.co;2-4","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2019.03.003","article-title":"Castleman disease","volume":"12","author":"Wang W","year":"2019","unstructured":"Wang W, Medeiros LJ. Castleman disease. Surg Pathol Clin. 2019, 12:849-63. 10.1016\/j.path.2019.03.003","journal-title":"Surg Pathol Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri A","year":"2020","unstructured":"Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020, 135:1353-64. 10.1182\/blood.2019000931","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15019","article-title":"The full spectrum of Castleman disease: 273 patients studied over 20\u00a0years","volume":"180","author":"Oksenhendler E","year":"2018","unstructured":"Oksenhendler E, Boutboul D, Fajgenbaum D, et al.. The full spectrum of Castleman disease: 273 patients studied over 20\u00a0years. Br J Haematol. 2018, 180:206-16. 10.1111\/bjh.15019","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23291","article-title":"The clinical spectrum of Castleman's disease","volume":"87","author":"Dispenzieri A","year":"2012","unstructured":"Dispenzieri A, Armitage JO, Loe MJ, et al.. The clinical spectrum of Castleman's disease. Am J Hematol. 2012, 87:997-1002. 10.1002\/ajh.23291","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003334","article-title":"International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease","volume":"4","author":"van Rhee F","year":"2020","unstructured":"van Rhee F, Oksenhendler E, Srkalovic G, et al.. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. 2020, 4:6039-50. 10.1182\/bloodadvances.2020003334","journal-title":"Blood Adv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02788-7","article-title":"Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging","volume":"477","author":"Lyapichev KA","year":"2020","unstructured":"Lyapichev KA, You MJ, Vega F, Solis LM, Medeiros LJ. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging. Virchows Arch. 2020, 477:437-44. 10.1007\/s00428-020-02788-7","journal-title":"Virchows Arch"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403716","article-title":"HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3","volume":"19","author":"Nagel S","year":"2005","unstructured":"Nagel S, Scherr M, Quentmeier H, Kaufmann M, Zaborski M, Drexler HG, MacLeod RA. HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3. Leukemia. 2005, 19:841-6. 10.1038\/sj.leu.2403716","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S60514","article-title":"Update and new approaches in the treatment of Castleman disease","volume":"7","author":"Chan KL","year":"2016","unstructured":"Chan KL, Lade S, Prince HM, Harrison SJ. Update and new approaches in the treatment of Castleman disease. J Blood Med. 2016, 7:145-58. 10.2147\/JBM.S60514","journal-title":"J Blood Med"},{"key":"ref11","article-title":"Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease","volume":"141","author":"Hsu SM","year":"1992","unstructured":"Hsu SM, Xie SS, Hsu PL, Waldron JA Jr. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. Am J Pathol. 1992, 141:129-38.","journal-title":"Am J Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1879","article-title":"Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma","volume":"19","author":"Marri PR","year":"2013","unstructured":"Marri PR, Hodge LS, Maurer MJ, et al.. Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma. Clin Cancer Res. 2013, 19:6812-9. 10.1158\/1078-0432.CCR-13-1879","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10022","article-title":"Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review","volume":"69","author":"Larroche C","year":"2002","unstructured":"Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, Piette JC, Raphael M. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol. 2002, 69:119-26. 10.1002\/ajh.10022","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.60052","article-title":"Three patients with both Hodgkin's lymphoma and Castleman's disease: clinicopathologic correlations and lack of association with HHV-8","volume":"30","author":"Haque S","year":"2009","unstructured":"Haque S, van Kirk R. Three patients with both Hodgkin's lymphoma and Castleman's disease: clinicopathologic correlations and lack of association with HHV-8. Indian J Med Paediatr Oncol. 2009, 30:76-9. 10.4103\/0971-5851.60052","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref15","article-title":"Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease)","volume":"120","author":"Abdel-Reheim FA","year":"1996","unstructured":"Abdel-Reheim FA, Koss W, Rappaport ES, Arber DA. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease). Arch Pathol Lab Med. 1996, 120:91-6.","journal-title":"Arch Pathol Lab Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198303000-00004","article-title":"Interfollicular Hodgkin's disease","volume":"7","author":"Doggett RS","year":"1983","unstructured":"Doggett RS, Colby TV, Dorfman RF. Interfollicular Hodgkin's disease. Am J Surg Pathol. 1983, 7:145-9. 10.1097\/00000478-198303000-00004","journal-title":"Am J Surg Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2017.11.009","article-title":"Hodgkin lymphoma with an interfollicular growth pattern: a clinicopathologic study of 8 cases","volume":"33","author":"AbdullGaffar B","year":"2018","unstructured":"AbdullGaffar B, Seliem RM. Hodgkin lymphoma with an interfollicular growth pattern: a clinicopathologic study of 8 cases. Ann Diagn Pathol. 2018, 33:30-4. 10.1016\/j.anndiagpath.2017.11.009","journal-title":"Ann Diagn Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo E","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011, 117:5019-32. 10.1182\/blood-2011-01-293050","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9423205","article-title":"Hodgkin lymphoma and Castleman disease: when one blood disease can hide another","volume":"2017","author":"Filliatre-Clement L","year":"2017","unstructured":"Filliatre-Clement L, Busby-Venner H, Moulin C, Roth-Guepin G, Perrot A. Hodgkin lymphoma and Castleman disease: when one blood disease can hide another. Case Rep Hematol. 2017, 2017:9423205. 10.1155\/2017\/9423205","journal-title":"Case Rep Hematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/487205","article-title":"Coexistence of Hodgkin's lymphoma and Castleman's disease: a case report with successful response to chemotherapy and radiotherapy","volume":"2013","author":"Mohtaram A","year":"2013","unstructured":"Mohtaram A, Afif M, Sghiri T, et al.. Coexistence of Hodgkin's lymphoma and Castleman's disease: a case report with successful response to chemotherapy and radiotherapy. Case Rep Oncol Med. 2013, 2013:487205. 10.1155\/2013\/487205","journal-title":"Case Rep Oncol Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185568-classical-hodgkin-lymphoma-on-the-background-of-castleman-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:43Z","timestamp":1707509143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185568-classical-hodgkin-lymphoma-on-the-background-of-castleman-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.44930","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,8]]}}}